Elgethun Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,129
| Closed | -$110K | – | 159 |
|
|
2024
Q4 | $110K | Sell |
4,129
-138
| -3% | -$3.74K | 0.03% | 146 |
|
|
2024
Q3 | $123K | Sell |
4,267
-1,038
| -20% | -$30.3K | 0.03% | 142 |
|
|
2024
Q2 | $148K | Buy |
5,305
+58
| +1% | +$1.6K | 0.04% | 135 |
|
|
2024
Q1 | $145K | Sell |
5,247
-968
| -16% | -$26.9K | 0.04% | 138 |
|
|
2023
Q4 | $179K | Buy |
6,215
+1,094
| +21% | +$33.1K | 0.05% | 121 |
|
|
2023
Q3 | $169K | Sell |
5,121
-2,076
| -29% | -$73.4K | 0.05% | 117 |
|
|
2023
Q2 | $264K | Buy |
7,197
+98
| +1% | +$3.81K | 0.08% | 100 |
|
|
2023
Q1 | $291K | Sell |
7,099
-3,195
| -31% | -$138K | 0.09% | 95 |
|
|
2022
Q4 | $525K | Sell |
10,294
-3,766
| -27% | -$181K | 0.19% | 69 |
|
|
2022
Q3 | $615K | Buy |
14,060
+3,084
| +28% | +$150K | 0.25% | 64 |
|
|
2022
Q2 | $574K | Buy |
10,976
+80
| +0.7% | +$4.08K | 0.22% | 67 |
|
|
2022
Q1 | $564K | Sell |
10,896
-156
| -1% | -$8.09K | 0.19% | 69 |
|
|
2021
Q4 | $630K | Sell |
11,052
-152
| -1% | -$7.53K | 0.22% | 65 |
|
|
2021
Q3 | $482K | Buy |
11,204
+385
| +4% | +$17.1K | 0.17% | 69 |
|
|
2021
Q2 | $424K | Buy |
10,819
+97
| +0.9% | +$3.77K | 0.15% | 74 |
|
|
2021
Q1 | $388K | Sell |
10,722
-511
| -5% | -$18.1K | 0.15% | 70 |
|
|
2020
Q4 | $413K | Buy |
11,233
+2,415
| +27% | +$88.6K | 0.18% | 68 |
|
|
2020
Q3 | $307K | Hold |
8,818
| – | – | 0.17% | 64 |
|
|
2020
Q2 | $251K | Hold |
8,818
| – | – | 0.15% | 72 |
|
|
2020
Q1 | $273K | Buy |
8,818
+231
| +3% | +$7.87K | 0.15% | 70 |
|
|
2019
Q4 | $320K | Hold |
8,587
| – | – | 0.16% | 72 |
|
|
2019
Q3 | $291K | Hold |
8,587
| – | – | 0.15% | 75 |
|
|
2019
Q2 | $353K | Sell |
8,587
-53
| -0.6% | -$2.1K | 0.19% | 66 |
|
|
2019
Q1 | $348K | Hold |
8,640
| – | – | 0.2% | 70 |
|
|
2018
Q4 | $355K | Sell |
8,640
-527
| -6% | -$21.9K | 0.25% | 72 |
|
|
2018
Q3 | $386K | Hold |
9,167
| – | – | 0.25% | 70 |
|
|
2018
Q2 | $315K | Buy |
9,167
+317
| +4% | +$10.8K | 0.22% | 73 |
|
|
2018
Q1 | $298K | Buy |
8,850
+674
| +8% | +$23.2K | 0.21% | 85 |
|
|
2017
Q4 | $281K | Buy |
+8,176
| New | +$279K | 0.2% | 78 |
|
|
2017
Q1 | – | Sell |
-4,803
| Closed | -$148K | – | 181 |
|
|
2016
Q4 | $148K | Buy |
+4,803
| New | +$147K | 0.12% | 86 |
|
Other funds holding PFE
TIM
Elgethun Capital Management's PFE Position: Q1 2025 in Review
Elgethun Capital Management sold out of Pfizer (PFE) in Q1 2025, closing a stake of 4,129 shares — an estimated $110K sold.
Elgethun Capital Management first reported a position in PFE in Q4 2016 and held it in 30 quarters. The position peaked at $630K in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Elgethun Capital Management reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Elgethun Capital Management sold 4,129 Pfizer shares in Q1 2025, an estimated $110K.
- Elgethun Capital Management first reported a position in Pfizer in Q4 2016 and held it in 30 quarters.
- Elgethun Capital Management's Pfizer position peaked at $630K in Q4 2021.
- 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Elgethun Capital Management's 13F filing for Q1 2025, filed 9 May 2025.